This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Epi-Foam Compression Foam, Designed For Post-Operative Liposuction Care, Only From Biodermis

HENDERSON, Nev., Jan. 17, 2013 /PRNewswire/ -- Epi-Foam is a unique, self-adhering medical grade silicone-backed post-operative compression foam device. It is worn immediately after both traditional and ultra-sonic liposuction procedures and provides a more even compression distribution. Improving compression distribution can assist in smoothing the skin and helping to reduce the "wavering" or "rippling" effect frequently associated with liposuction.  It can also help in reducing post-operative bruising and swelling.

Epi-Foam adheres gently to the skin by using the highest quality medical grade silicone. The adhesion is just enough to keep the pad in place, thus minimizing blistering or shearing.  Furthermore, silicone won't stick to the skin or cause pain and discomfort when removed, as typically experienced when using Reston™.

Unprecedented patient comfort is achieved by using only the most advanced soft, small cell, polyurethane materials to create the compression barrier between the patient's skin and the post-operative garment.  Polyurethane foam also provides for exceptional conformance to three-dimensional contours such as hips, waist, thighs, and chins.

"We believe  Epi - Foam  post-operative compression pads fill a gap in the post-operative recovery market, providing patients with unmatched comfort, minimized pain, and superior results that are simply not possible with any other product." Jeff Schleuning, Ph.D. EVP, Partner, Biodermis 

Each Epi-Foam pad is 7.75" x 11.50" and they are packaged in sets of three.

Established in 1988, Biodermis has been recognized for its innovative contributions to the scar management and post-operative care industry for more than 25 years. For more information regarding Epi-Foam, log on at biodermis.com or call (702) 260-4466.

CONTACT: Sean Mahoney, Biodermis, (702) 260-4466

SOURCE Biodermis

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,132.70 -81.72 -0.45%
S&P 500 2,104.50 -6.24 -0.30%
NASDAQ 4,963.5270 -24.3630 -0.49%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs